Peyman Björklund
Forskare i experimentell endokrinkirurgi vid Institutionen för kirurgiska vetenskaper
- Telefon:
- 018-471 47 02, 070-167 94 02
- Mobiltelefon:
- 070-167 94 02
- E-post:
- peyman.bjorklund@uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 70, 1tr
- Postadress:
- Akademiska sjukhuset, ingång 70, 1tr
751 85 UPPSALA
Ladda ned kontaktuppgifter för Peyman Björklund vid Institutionen för kirurgiska vetenskaper
- Akademiska meriter:
- PhD
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Urval av publikationer
- Activating mutations in CTNNB1 in aldosterone producing adenomas (2016)
- Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas (2015)
- Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis. (2015)
- Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors (2015)
- Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing (2015)
- Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors (2015)
- Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture (2015)
- Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas. (2015)
- MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours (2014)
- Integrative Genetic Characterization and Phenotype Correlations in Pheochromocytoma and Paraganglioma Tumours (2014)
- Targeted Next Generation Sequencing in the Screening for Familial Neuroendocrine Tumor Syndromes (2014)
- Global DNA methylation patterns in small intestinal neuroendocrine tumors (SI-NETs) (2014)
- TCEB3C a putative tumor suppressor gene of small intestine neuroendocrine tumors (2014)
- Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors (2014)
- Molecular derangements in primary aldosteronism (2014)
- Bisphenol A increases cortisol production by enhancing phosphorylation of CREB in normal human adrenocortical cells (2014)
- Induction of LINE-1 promoter hypomethylation, a hallmark of tumorigenesis, in normal human adrenocortical cells by Bisphenol A (2014)
- Peritoneal carcinomatosis from small intestinal neuroendocrine tumors (2014)
- The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors (2014)
- Treatment, prognostic markers and survival in thymic neuroendocrine tumours (2013)
- Metastases from Neuroendocrine Tumors to the Breast Are More Common than Previously Thought. A Diagnostic Pitfall? (2013)
- Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma (2013)
- Somatic Mutations in H-RAS in Sporadic Pheochromocytoma and Paraganglioma Identified by Exome Sequencing (2013)
- TCEB3C (Elongin A3) on chromosome 18 presents a putative tumor suppressor gene of small intestine neuroendocrine tumors. (2013)
- Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism (2013)
- Culture of Parathyroid Cells (2012)
- Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors (2012)
- Evidence of a stabilizing mutation of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas (2012)
- Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification (2012)
- Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter (2012)
- K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension (2011)
- Different gene expression profiles in metastasizing midgut carcinoid tumors (2011)
- Clinical and histopathological characteristics of hyperparathyroidism-induced hypercalcemic crisis (2011)
- 4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism (2011)
- Metastatic Colon Cancer to the Thyroid Gland in the Setting of Pathologically Diagnosed Papillary Thyroid Cancer (2011)
- The DNA Methylome of Benign and Malignant Parathyroid Tumors (2011)
- Stathmin as a Marker for Malignancy in Pheochromocytomas (2010)
- Molecular Basis of Primary Hyperparathyroidism (2010)
- Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients (2010)
- Expression and somatic mutations of SDHAF2 (SDH5), a novel endocrine tumor suppressor gene in parathyroid tumors of primary hyperparathyroidism (2010)
- Aberrant WNT/β-catenin signaling in parathyroid carcinoma. (2010)
- The internally truncated LRP5 receptor presents a therapeutic target in breast cancer (2009)
- Molecular genetics of parathyroid disease. (2009)
- Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen (2008)
- Type I membrane Klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism (2008)
- Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients (2008)
- A LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated Wnt/β-catenin signaling (2007)
- Activated β-catenin in the novel human parathyroid tumor cell line sHPT-1 (2007)
- Accumulation of nonphosphorylated β-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors (2007)
- Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells (2007)
- Potentiating effects of non-active/active vitamin D analogues and ketoconazole in parathyroid cells (2007)
- 25-hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-hydroxylated vitamin D analogue (2005)
- Activating Mutations in CTNNB1 in Aldosterone Producing Adenomas
Senaste publikationer
- Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause (2021)
- RNA Sequencing Provides Novel Insights into the Transcriptome of Aldosterone Producing Adenomas (2019)
- Aldosterone-Producing Adenomas (2019)
- Epigenetics of pheochromocytoma and paraganglioma (2018)
- Comprehensive analysis of CTNNB1 in adrenocortical carcinomas (2018)
Alla publikationer
Artiklar
- Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause (2021)
- RNA Sequencing Provides Novel Insights into the Transcriptome of Aldosterone Producing Adenomas (2019)
- Epigenetics of pheochromocytoma and paraganglioma (2018)
- Comprehensive analysis of CTNNB1 in adrenocortical carcinomas (2018)
- Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations (2017)
- A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors (2017)
- Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1 (2017)
- Precision medicine in pheochromocytoma and paraganglioma (2016)
- Activating mutations in CTNNB1 in aldosterone producing adenomas (2016)
- Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in insulin-producing adenomas (2015)
- Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis. (2015)
- Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors (2015)
- Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing (2015)
- Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors (2015)
- Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture (2015)
- A review on management discussions of small intestinal neuroendocrine tumors 'midgut carcinoids' (2015)
- Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas. (2015)
- MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours (2014)
- Integrative Genetic Characterization and Phenotype Correlations in Pheochromocytoma and Paraganglioma Tumours (2014)
- Targeted Next Generation Sequencing in the Screening for Familial Neuroendocrine Tumor Syndromes (2014)
- Global DNA methylation patterns in small intestinal neuroendocrine tumors (SI-NETs) (2014)
- TCEB3C a putative tumor suppressor gene of small intestine neuroendocrine tumors (2014)
- Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors (2014)
- Bisphenol A increases cortisol production by enhancing phosphorylation of CREB in normal human adrenocortical cells (2014)
- Induction of LINE-1 promoter hypomethylation, a hallmark of tumorigenesis, in normal human adrenocortical cells by Bisphenol A (2014)
- Peritoneal carcinomatosis from small intestinal neuroendocrine tumors (2014)
- The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors (2014)
- Treatment, prognostic markers and survival in thymic neuroendocrine tumours (2013)
- Metastases from Neuroendocrine Tumors to the Breast Are More Common than Previously Thought. A Diagnostic Pitfall? (2013)
- Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma (2013)
- Somatic Mutations in H-RAS in Sporadic Pheochromocytoma and Paraganglioma Identified by Exome Sequencing (2013)
- TCEB3C (Elongin A3) on chromosome 18 presents a putative tumor suppressor gene of small intestine neuroendocrine tumors. (2013)
- Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism (2013)
- Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors (2012)
- Evidence of a stabilizing mutation of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas (2012)
- Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene epigenetically deregulated in hyperparathyroid tumors by histone H3 lysine modification (2012)
- Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter (2012)
- K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension (2011)
- Different gene expression profiles in metastasizing midgut carcinoid tumors (2011)
- Clinical and histopathological characteristics of hyperparathyroidism-induced hypercalcemic crisis (2011)
- 4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism (2011)
- Metastatic Colon Cancer to the Thyroid Gland in the Setting of Pathologically Diagnosed Papillary Thyroid Cancer (2011)
- The DNA Methylome of Benign and Malignant Parathyroid Tumors (2011)
- Stathmin as a Marker for Malignancy in Pheochromocytomas (2010)
- Molecular Basis of Primary Hyperparathyroidism (2010)
- Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients (2010)
- Expression and association of TRPC subtypes with Orai1 and STIM1 in human parathyroid (2010)
- Expression and somatic mutations of SDHAF2 (SDH5), a novel endocrine tumor suppressor gene in parathyroid tumors of primary hyperparathyroidism (2010)
- Aberrant WNT/β-catenin signaling in parathyroid carcinoma. (2010)
- Aberrant WNT/beta-catenin signaling in parathyroid carcinoma (2010)
- The internally truncated LRP5 receptor presents a therapeutic target in breast cancer (2009)
- Role of follistatin in promoting adipogenesis in women (2009)
- Molecular genetics of parathyroid disease. (2009)
- Molecular Genetics of Parathyroid Disease (2009)
- Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen (2008)
- Type I membrane Klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism (2008)
- Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients (2008)
- A LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated Wnt/β-catenin signaling (2007)
- Activated β-catenin in the novel human parathyroid tumor cell line sHPT-1 (2007)
- Accumulation of nonphosphorylated β-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors (2007)
- Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells (2007)
- Potentiating effects of non-active/active vitamin D analogues and ketoconazole in parathyroid cells (2007)
- 25-hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-hydroxylated vitamin D analogue (2005)
- Activating Mutations in CTNNB1 in Aldosterone Producing Adenomas
Böcker
Kapitel
- Aldosterone-Producing Adenomas (2019)
- Molecular derangements in primary aldosteronism (2014)
- Culture of Parathyroid Cells (2012)
- Parathyroid carcinoma (2009)